Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia

被引:0
|
作者
Patrick Salwierz
Simrika Thapa
Foad Taghdiri
Anna Vasilevskaya
Chloe Anastassiadis
David F. Tang-Wai
Angela C. Golas
M. Carmela Tartaglia
机构
[1] University of Toronto,Tanz Centre for Research in Neurodegenerative Diseases, Temerty Faculty of Medicine
[2] University of Toronto,Division of Neurology, Department of Medicine
[3] Memory Clinic University Health Network,Department of Psychiatry, Temerty Faculty of Medicine
[4] Krembil Brain Institute,undefined
[5] Centre for Addiction and Mental Health,undefined
[6] University of Toronto,undefined
来源
GeroScience | 2024年 / 46卷
关键词
Major depressive disorder; Alzheimer’s disease; Cerebrovascular disease; Cerebrospinal fluid biomarkers; White matter hyperintensities;
D O I
暂无
中图分类号
学科分类号
摘要
The association between depression and dementia, particularly Alzheimer’s disease (AD) and cerebrovascular disease (CVD), remains an active area of research. This study aimed to investigate the relationship between a history of depression and biomarkers of AD and CVD in patients with dementia in a clinical setting. A total of 126 patients from the University Health Network (UHN) Memory Clinic with comprehensive clinical evaluations, including neuropsychological testing and medical examinations, were included. Lumbar puncture was performed to collect cerebrospinal fluid (CSF) for biomarker analysis, and brain magnetic resonance imaging (MRI) scans were obtained to assess white matter hyperintensity (WMH) burden. The presence of depression was determined through medical records. The study findings did not reveal significant differences between participants with and without a history of depression in terms of AD biomarkers, WMH burden, neurofilament light chain levels, cognitive scores, age of symptom onset, disease duration, or vascular risk scores. Logistic regression analysis did not indicate a meaningful predictive value of these variables for depression status. This clinical study contributes to our understanding regarding the association between depression and AD/CVD biomarkers in patients with cognitive impairment. Further research is needed to elucidate the complex relationship between depression and dementia and to explore the potential mechanisms linking depression, AD, and CVD.
引用
收藏
页码:783 / 793
页数:10
相关论文
共 50 条
  • [31] CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
    Delvenne, Aurore
    Gobom, Johan
    Schindler, Suzanne E.
    ten Kate, Mara
    Reus, Lianne M.
    Dobricic, Valerija
    Tijms, Betty M.
    Benzinger, Tammie L. S.
    Cruchaga, Carlos
    Teunissen, Charlotte E.
    Ramakers, Inez
    Martinez-Lage, Pablo
    Tainta, Mikel
    Vandenberghe, Rik
    Schaeverbeke, Jolien
    Engelborghs, Sebastiaan
    De Roeck, Ellen
    Popp, Julius
    Peyratout, Gwendoline
    Tsolaki, Magda
    Freund-Levi, Yvonne
    Lovestone, Simon
    Streffer, Johannes
    Barkhof, Frederik
    Bertram, Lars
    Blennow, Kaj
    Zetterberg, Henrik
    Visser, Pieter Jelle
    Vos, Stephanie J. B.
    ALZHEIMERS & DEMENTIA, 2024, 20 (09) : 6205 - 6220
  • [32] Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer's disease
    Huang, Xiao
    Zhao, Jialing
    Wang, Qinghua
    Yan, Tingqi
    Gou, Shu
    Zhu, Xiaofeng
    Yang, Liu
    Ye, Fang
    Zhang, Jie
    Wang, Yanjiang
    Yang, Shaojie
    Le, Weidong
    Xiang, Yang
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (02)
  • [33] Recent Updates on the Association Between Alzheimer's Disease and Vascular Dementia
    Ashraf, Ghulam M.
    Chibber, Sandesh
    Mohammad
    Zaidi, Syed K.
    Tabrez, Shams
    Ahmad, Ausaf
    Shakil, Shazi
    Mushtaq, Gohar
    Baeesa, Saleh S.
    Kamal, Mohammad A.
    MEDICINAL CHEMISTRY, 2016, 12 (03) : 226 - 237
  • [34] Similarities between Alzheimer's disease and vascular dementia
    Kalaria, R
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 203 : 29 - 34
  • [35] Effect of galantamine on attention in patients with Alzheimer's disease combined with cerebrovascular disease
    Park, Jeong Jin
    Choi, Seong Hye
    Kim, SangYun
    Lee, Ae Young
    Moon, So Young
    Lee, Jun Hong
    Kwon, Jae Cheol
    Park, Kyung Won
    Ku, Bon D.
    Han, Hyun Jeong
    Kim, Eun-Joo
    Shim, Yong S.
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (10) : 1661 - 1666
  • [36] Association of Nutrients with Biomarkers of Alzheimer's Disease
    Kalli, Efstathia G.
    GENEDIS 2016: GENETICS AND NEURODEGENERATION, 2017, 987 : 257 - 268
  • [37] Association between behavioural and psychological symptoms of dementia and residence status in patients with Alzheimer's disease
    Midorikawa, Haruhiko
    Ekoyama, Saori
    Tachikawa, Hirokazu
    Ota, Miho
    Tamura, Masashi
    Takahashi, Takumi
    Sekine, Aya
    Ide, Masayuki
    Matsuzaki, Asaki
    Nemoto, Miyuki
    Nemoto, Kiyotaka
    Arai, Tetsuaki
    PSYCHOGERIATRICS, 2023, 23 (01) : 45 - 51
  • [38] Family History of Alzheimer's Disease and Cortical Thickness in Patients With Dementia
    Ganske, Steffi
    Haussmann, Robert
    Gruschwitz, Antonia
    Werner, Annett
    Osterrath, Antje
    Baumgaertel, Johanna
    Lange, Jan
    Donix, Katharina L.
    Linn, Jennifer
    Donix, Markus
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 450 - 456
  • [39] Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia
    Wu, Liu-Yun
    Cheah, Irwin K.
    Chong, Joyce Ruifen
    Chai, Yuek Ling
    Tan, Jia Yun
    Hilal, Saima
    Vrooman, Henri
    Chen, Christopher P.
    Halliwell, Barry
    Lai, Mitchell K. P.
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 177 : 201 - 211
  • [40] Depression as a Risk Factor for Dementia and Alzheimer's Disease
    Canton-Habas, Vanesa
    Rich-Ruiz, Manuel
    Romero-Saldana, Manuel
    Carrera-Gonzalez, Maria del Pilar
    BIOMEDICINES, 2020, 8 (11) : 1 - 15